AAMI to offer user-friendly guide to MDDS

Seeking to render the FDA’s Feb. 2011 rule on medical device data systems (MDDS) in user-friendly language, the Association for the Advancement of Medical Instrumentation (AAMI) has crafted a new guide.

The association introduced a pre-publication version of the document, AAMI SW87, at a conference convened jointly with FDA in Herndon, Va., March 21-22.

Under the rule, any hospital or healthcare provider that modifies an MDDS can be considered a manufacturer. As such, it would be subject to the relevant regulations and required to adopt a quality assurance system by April 18.

AAMI said in a news release that it expects to publish its guide by mid-April, pointing out that the document will be aimed at MDDS newcomers.

“We are still at the stage of outreach,” said John Murray, FDA medical device software compliance expert and co-chair of AAMI’s medical software committee, which developed the document. “There are a lot of folks that haven’t heard of MDDS or quality system regulations.”

He told conference attendees that between 90 and 100 entities have so far registered with FDA as MDDS manufacturers, four of which are hospitals.

Murray also said no hospital inspections are planned and that FDA has set no specific MDDS compliance policy.

AAMI did not specify in what form it will publish its guide or how to obtain a copy.

FDA has posted resources to help with identifying an MDDS and complying with the MDDS rule.
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.